Wolters Kluwer Health
may email you for journal alerts and information, but is committed
to maintaining your privacy and will not share your personal information without
your express consent. For more information, please refer to our Privacy Policy.

Methods: Thirty-three patients with 55 HCCs underwent 1.5-T MRI by means of fat-suppressed T1-weighted sequence obtained before and after gadobenate dimeglumine administration, during early and late arterial phases, PVP (70 seconds), and DP (180 seconds). Detection rates of contrast washout of hypervascular HCCs and tumor-to-liver contrast on PVP and DP were measured and compared.

The authors have no conflicts of interest, and there are no funding sources for the study.

Presented as scientific poster at the 20th Annual Meeting and Postgraduate Course of the European Society of Gastrointestinal and Abdominal Radiology, Valencia, Spain, June 23-26, 2009 (P-172) and at the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America, Chicago, Ill, November 29-December 4 (LL-GI2255-L05).

Dr Furlan is now with the Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, PA.